Body fat composition and miR-378 expression profiling in patients with type 1 diabetes
0
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Purpose: Type 1 diabetes (T1D) is an autoimmune disease that involves genetic, epigenetic, and environmental factors. Change in body composition is a potential mechanism for explaining the increased incidence of T1D. Micro RNA-378 (miRNA-378) is a positive regulator of adipogenesis that has yet to be studied in such patients. This study aims to evaluate the miRNA-378 expression profile in peripheral mononuclear cells of T1D patients and controls and to determine its possible association with levels of body fat, interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α). Methods: Twenty-four T1D subjects and 20 controls under 18 years of age without autoimmune diseases were studied. miRNA-378 expression profile was determined by TaqMan probes. Body composition was determined by multifrequency bioimpedance. IL-6 and TNF-α serum levels were determined by LUMINEX. Anti-GAD65, anti-IA2, and anti-ZnT8 antibodies were quantified in serum by enzyme immunoassays. Statistical significance was considered P<0.05. Results: Similar body mass index and body fat (kg) were observed between the T1D and control subjects (P=0.55 and P=0.69, respectively). The miRNA-378 expression profile was significantly higher in T1D patients compared with the controls (P<0.05). Lower miRNA-378 expression in prepubertal controls was observed compared to pubertal controls, prepubertal T1D, and pubertal T1D (P<0.05). AntiGAD65, AntilA2, and AntiZnT8 were positively correlated with miRNA-378 (P=0.002, P=0.053, and P=0.007). No statistically significant correlation was observed between miRNA-378 expression and IL-6, TNF-α, or body fat. Conclusion: Elevated miRNA-378 expression in T1D patients compared with controls is linked to pubertal stage but is not associated with proinflammatory status or body composition.
Abstract
Purpose: Type 1 diabetes (T1D) is an autoimmune disease that involves genetic, epigenetic, and environmental factors. Change in body composition is a potential mechanism for explaining the increased incidence of T1D. Micro RNA-378 (miRNA-378) is a positive regulator of adipogenesis that has yet to be studied in such patients. This study aims to evaluate the miRNA-378 expression profile in peripheral mononuclear cells of T1D patients and controls and to determine its possible association with levels of body fat, interleukin-6 (IL-6), and tumor necrosis factor alpha (TNF-α). Methods: Twenty-four T1D subjects and 20 controls under 18 years of age without autoimmune diseases were studied. miRNA-378 expression profile was determined by TaqMan probes. Body composition was determined by multifrequency bioimpedance. IL-6 and TNF-α serum levels were determined by LUMINEX. Anti-GAD65, anti-IA2, and anti-ZnT8 antibodies were quantified in serum by enzyme immunoassays. Statistical significance was considered P<0.05. Results: Similar body mass index and body fat (kg) were observed between the T1D and control subjects (P=0.55 and P=0.69, respectively). The miRNA-378 expression profile was significantly higher in T1D patients compared with the controls (P<0.05). Lower miRNA-378 expression in prepubertal controls was observed compared to pubertal controls, prepubertal T1D, and pubertal T1D (P<0.05). AntiGAD65, AntilA2, and AntiZnT8 were positively correlated with miRNA-378 (P=0.002, P=0.053, and P=0.007). No statistically significant correlation was observed between miRNA-378 expression and IL-6, TNF-α, or body fat. Conclusion: Elevated miRNA-378 expression in T1D patients compared with controls is linked to pubertal stage but is not associated with proinflammatory status or body composition.
참고문헌 (40)
- Pugliese A, "The multiple origins of type 1 diabetes", Diabet Med, 30, pp.135~146 (2013)
- Nokoff N, "Pathogenesis of type 1 diabetes : lessons from natural history studies of high-risk individuals", Ann N Y Acad Sci, 1281, pp.1~15 (2013)
- Carrasco E, "One of the lowest validated incidence rates of insulin dependent diabetes mellitus in the Americas: Santiago, Chile", Diabetes Res Clin Pract, 34(Suppl), pp.S153~S157 (1996)
- Carrasco E, "Increasing incidence of type 1 diabetes in population from Santiago of Chile: trends in a period of 18 years (1986-2003)", Diabetes Metab Res Rev, 22, pp.34~37 (2006)
- Hewagama A, "The genetics and epigenetics of autoimmune diseases", J Autoimmun, 33, pp.3~11 (2009)
- Wang YC, "Health and economic burden of the projected obesity trends in the USA and the UK", Lancet, 378, pp.815~825 (2011)
- "Informe Mapa Nutricional 2015" (2016)[URL]
- Weisberg SP, "Obesity is associated with macrophage accumulation in adipose tissue", J Clin Invest, 112, pp.1796~1808 (2003)
- Hotamisligil GS, "Adipose expression of tumor necrosis factor-alpha : direct role in obesity-linked insulin resistance", Science, 259, pp.87~91 (1993)
- Poy MN, "A pancreatic islet-specific microRNA regulates insulin secretion", Nature, 432, pp.226~230 (2004)
- Ono K, "MicroRNA links obesity and impaired glucose metabolism", Cell Res, 21, pp.864~866 (2011)
- Xu LL, "TNF-α, IL-6, and leptin increase the expression of miR-378, an adipogenesis-related microRNA in human adipocytes", Cell Biochem Biophys, 70, pp.771~776 (2014)
- Carrer M, "Control of mitochondrial metabolism and systemic energy homeostasis by microRNAs 378 and 378*", Proc Natl Acad Sci U S A, 109, pp.15330~15335 (2012)
- Kahai S, "MicroRNA miR-378 regulates nephronectin expression modulating osteoblast differentiation by targeting GalNT-7", PLoS One, 4, pp.e7535~ (2009)
- Lee DY, "MicroRNA-378promotes cell survival, tumor growth, and angiogenesis by targeting SuFu and Fus-1 expression", Proc Natl Acad Sci U S A, 104, pp.20350~20355 (2007)
- WHO Multicentre Growth Reference Study Group, "WHO child growth standards: Length", height-for-age, weightfor-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development, 2006
- Flechtner-Mors M, "Overweight and obesity based on four reference systems in 18, 382paediatric patients with type 1 diabetes from Germany and Austria", J Diabetes Res, 2015, pp.370753~ (2015)
- DuBose SN, "Obesity in youth with type 1 diabetes in Germany, Austria, and the United States", J Pediatr, 167, pp.627-32.e1~627-32.e4 (2015)
- Mosso C, "Dietary intake, body composition, and physical activity among young patients with type 1 diabetes mellitus", J Pediatr Endocrinol Metab, 28, pp.895~902 (2015)
- Gregory JW, "Body fat and overweight among children and adolescents with diabetes mellitus", Diabet Med, 9, pp.344~348 (1992)
- Ahmed ML, "Elevated leptin levels are associated with excess gains in fat mass in girls, but not boys, with type 1 diabetes : longitudinal study during adolescence", J Clin Endocrinol Metab, 86, pp.1188~1193 (2001)
- Manyanga T, "Not as skinny as we used to think : Body mass index in children and adolescents at diagnosis of type 1 diabetes mellitus", J Diabetes Complications, 30, pp.292~294 (2016)
- Holl RW, "Contributions of age, gender and insulin administration to weight gain in subjects with IDDM", Diabetologia, 41, pp.542~547 (1998)
- Dunger D, "Growth and body composition in type 1 diabetes mellitus", Horm Res, 58(Suppl 1), pp.66~71 (2002)
- Smart CE, "ISPAD Clinical Practice Consensus Guidelines 2014. Nutritional management in children and adolescents with diabetes", Pediatr Diabetes, 15(Suppl 20), pp.135~153 (2014)
- Abd El Dayem SM, "Bone density, body composition, and markers of bone remodeling in type 1 diabetic patients", Scand J Clin Lab Invest, 71, pp.387~393 (2011)
- Paulino MF, "Growth and body composition in children with type 1 diabetes mellitus", Arch Bras Endocrinol Metab, 50, pp.490~498 (2006)
- Lipsky LM, "Body mass index and adiposity indicators associated with cardiovascular biomarkers in youth with type 1 diabetes followed prospectively", Pediatr Obes, 12, pp.468~476 (2017)
- Alnek K, "Increased blood levels of growth factors, proinflammatory cytokines, and th17 cytokines in patients with newly diagnosed type 1 diabetes", PLoS One, 10, pp.e0142976~ (2015)
- Dufour CR, "Genome-wide orchestration of cardiac functions by the orphan nuclear receptors ERRalpha and gamma", Cell Metab, 5, pp.345~356 (2007)
- Lowell BB, "Mitochondrial dysfunction and type 2 diabetes", Science, 307, pp.384~387 (2005)
- Patti ME, "Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes:Potential role of PGC1 and NRF1", Proc Natl Acad Sci U S A, 100, pp.8466~8471 (2003)
- Ishida M, "MicroRNA-378 regulates adiponectin expression in adipose tissue: a new plausible mechanism", PLoS One, 9, pp.e111537~ (2014)
- Gerin I, "Roles for miRNA-378", 378* in adipocyte gene expression and lipogenesis, 2010, pp.299, E198~E206
- Assmann TS, "MicroRNA expression profiles and type 1diabetes mellitus : systematic review and bioinformatic analysis", Endocr Connect, 6, pp.773~790 (2017)
- Perrini S, "Fat depot-related differences in gene expression, adiponectin secretion, and insulin action and signalling in human adipocytes differentiated in vitro from precursor stromal cells", Diabetologia, 51, pp.155~164 (2008)
- Wilkin TJ, "The accelerator hypothesis : a review of the evidence for insulin resistance as the basis for type I as well as type II diabetes", Int J Obes(Lond), 33, pp.716~726 (2009)
- Park E, "Estrogen receptor-related receptor γ regulates testicular steroidogenesis through direct and indirect regulation of steroidogenic gene expression", Mol Cell Endocrinol, 452, pp.15~24 (2017)
- Salas-Pérez F, "MicroRNAs miR-21a and miR-93 are down regulated in peripheral blood mononuclear cells(PBMCs)from patients with type 1 diabetes", Immunobiology, 218, pp.733~737 (2013)
- Sebastiani G, "Increased expression of microRNA miR-326 in type 1 diabetic patients with ongoing islet autoimmunity", Diabetes Metab Res Rev, 27, pp.862~866 (2011)
